Medica SpA (MIL:MDC) ROCE % : 13.08% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medica SpA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medica SpA's annualized ROCE % for the quarter that ended in Dec. 2023 was 13.08%.

Medica SpA ROCE % Historical Data

The historical data trend for Medica SpA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medica SpA ROCE % Chart

Medica SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.01

15.22

12.63

8.11

5.68

Medica SpA Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial					15.66	6.11	9.45	0.42	13.08

Medica SpA ROCE % Calculation

Medica SpA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4.618	/	( ( (129.723 - 46.584)	+	(119.566 - 40.224) )	/ 2 )
	=	4.618	/	( (83.139	+	79.342)	/ 2 )
	=	4.618	/	81.2405
	=	5.68 %

Medica SpA's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	8.942	/	( ( (128.836 - 71.416)	+	(119.566 - 40.224) )	/ 2 )
	=	8.942	/	( ( 57.42	+	79.342 )	/ 2 )
	=	8.942	/	68.381
	=	13.08 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Medica SpA (MIL:MDC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medica SpA ROCE % Related Terms

Thank you for viewing the detailed overview of Medica SpA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medica SpA (MIL:MDC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medica SpA (MIL:MDC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Via Degli Artigiani, 7, Medolla, ITA, 41036

Website

https://www.medica.it

Medica SpA is engaged in the development, production, and sale of blood purification products. Some of its product includes plasma fractionators; plasma filters; pico smart and others.